Insulet (PODD) P/E ratio

P/E ratio today
23.7×

Insulet (PODD) trades at 23.7× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 81.7×. That is 80.8% higher than the 45.2× of fiscal 2024. Figures as of 18 Nov 2026, 08:39 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/E ratio today
23.7×
P/E ratio, fiscal 2025
81.7×
Change on fiscal 2024
+80.8%
Highest on record
81.7×fiscal 2025
Lowest on record
45.2×fiscal 2024
Fiscal years on record
32023–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Insulet P/E ratio, in more detail

Today's figure is 70.9% below the fiscal 2025 year-end.

Across the 3 fiscal year-ends on record (2023–2025), the highest was 81.7× in fiscal 2025 and the lowest 45.2× in fiscal 2024. Today's P/E ratio is at or below every one of the 3 fiscal year-ends on record; their median is 73.8×.

History · 3 fiscal years

P/E ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Insulet P/E ratio, year by year

Insulet (PODD) P/E ratio by fiscal year
Fiscal yearP/E ratioChangeYear endedShare price at year-endDiluted EPS
Today23.7×—$145.34—
202581.7× 80.8% up$284.24$3.48
202445.2× 38.8% down$261.07$5.78
202373.8×—$216.98$2.94
2022——$294.39$0.07
2021——$266.07$0.24
2020——$255.63$0.10
2019——$171.20$0.19
2018——$79.32$0.05
2017——$69.00-$0.46
2016——$37.68-$0.48
2015——$37.81—
2014——$46.06—
2013——$37.10—
2012——$21.22—
2011——$18.83—
2010——$15.50—
2009——$14.28—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

P/E ratio at health care companies of similar size

P/E ratio of Insulet and comparable companies
CompanyP/E ratio
Bio-Rad Laboratories BIO9.5×
Qiagen QGEN26.9×
Insulet PODD23.7×

Price over the last twelve months' earnings per share, as the market data feed reports it.

More on PODD

Insulet, figure by figure

Insulet (PODD) overview: price, valuation and scorecardAll health care companies by market value

Insulet P/E ratio: questions and answers

What is Insulet's P/E ratio?

Insulet (PODD) trades at 23.7× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 81.7×. That is 80.8% higher than the 45.2× of fiscal 2024.

Is Insulet's P/E ratio high or low compared with its own history?

Today's P/E ratio is at or below every one of the 3 fiscal year-ends on record; their median is 73.8×.

What are the highest and lowest P/E ratio figures on record for Insulet?

Across the 3 fiscal year-ends on record (2023–2025), the highest was 81.7× in fiscal 2025 and the lowest 45.2× in fiscal 2024.

How is Insulet's P/E ratio calculated?

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Insulet (PODD) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/PODD/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.